Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers' Opdivo snags FDA priority review for bigger lung cancer use
Bristol-Myers' Opdivo snags FDA priority review for bigger lung cancer use
Bristol-Myers' Opdivo snags FDA priority review for bigger lung cancer use
Submitted by
admin
on September 2, 2015 - 10:16am
Source:
Fierce Pharma Marketing
News Tags:
Opdivo
Bristol-Myers Squibb
FDA
priority review
non-small cell lung cancer
Headline:
Bristol-Myers' Opdivo snags FDA priority review for bigger lung cancer use
Do Not Allow Advertisers to Use My Personal information
